Tonix Pharma (TNXP) PT Raised to $6.50 at Alliance Global Partners
Tweet Send to a Friend
Alliance Global Partners analyst James Molloy raised the price target on Tonix Pharma (NASDAQ: TNXP) to $6.50 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
